Multimodal Neuroimaging-Informed Clinical Applications in Neuropsychiatric Disorders

Recent advances in neuroimaging data acquisition and analysis hold the promise to enhance the ability to make diagnostic and prognostic predictions and perform treatment planning in neuropsychiatric disorders. Prior research using a variety of types of neuroimaging techniques has confirmed that neuropsychiatric disorders are associated with dysfunction in anatomical and functional brain circuits. We first discuss current challenges associated with the identification of reliable neuroimaging markers for diagnosis and prognosis in mood disorders and for neurosurgical treatment planning for deep brain stimulation (DBS). We then present data on the use of neuroimaging for the diagnosis and prognosis of mood disorders and for DBS treatment planning. We demonstrate how multivariate analyses of functional activation and connectivity parameters can be used to differentiate patients with bipolar disorder from those with major depressive disorder and non-affective psychosis. We also present data on connectivity parameters that mediate acute treatment response in affective and non-affective psychosis. We then focus on precision mapping of functional connectivity in native space. We describe the benefits of integrating anatomical fiber reconstruction with brain functional parameters and cortical surface measures to derive anatomically-informed connectivity metrics within the morphological context of each individual brain. We discuss how this approach may be particularly promising in psychiatry, given the clinical and etiological heterogeneity of the disorders, and particularly in treatment response prediction and planning. Precision mapping of connectivity is essential for DBS. In DBS, treatment electrodes are inserted into positions near key grey matter nodes within the circuits considered relevant to disease expression. However, targeting white matter tracts that underpin connectivity within these circuits may increase treatment efficacy and tolerability therefore relevant for effective treatment. We demonstrate how this approach can be validated in the treatment of Parkinson’s disease by identifying connectivity patterns that can be used as biomarkers for treatment planning and thus refine the traditional approach of DBS planning that uses only grey matter landmarks. Finally we describe how this approach could be used in planning DBS treatment of psychiatric disorders

Neuroimaging and electrophysiology meet invasive neurostimulation for causal interrogations and modulations of brain states

Deep brain stimulation (DBS) has developed over the last twenty years into a highly effective evidenced-based treatment option for neuropsychiatric disorders. Moreover, it has become a fascinating tool to provide illustrative insights into the functioning of brain networks. New anatomical and pathophysiological models of DBS action have accelerated our understanding of neurological and psychiatric disorders and brain functioning. The description of the brain networks arose through the unique ability to illustrate long-range interactions between interconnected brain regions as derived from state-of-the-art neuroimaging (structural, diffusion, and functional MRI) and the opportunity to record local and large-scale brain activity at millisecond temporal resolution (microelectrode recordings, local field potential, electroencephalography, and magnetoencephalography). In the first part of this review, we describe how neuroimaging techniques have led to current understanding of DBS effects, by identifying and refining the DBS targets and illustrate the actual view on the relationships between electrode locations and clinical effects. One step further, we discuss how neuroimaging has shifted the view of localized DBS effects to a modulation of specific brain circuits, which has been possible from the combination of electrode location reconstructions with recently introduced network imaging methods. We highlight how these findings relate to clinical effects, thus postulating neuroimaging as a key factor to understand the mechanisms of DBS action on behavior and clinical effects. In the second part, we show how invasive electrophysiology techniques have been efficiently integrated into the DBS set-up to precisely localize the neuroanatomical targets of DBS based on distinct region-specific patterns of neural activity. Next, we show how multi-site electrophysiological recordings have granted a real-time window into the aberrant brain circuits within and beyond DBS targets to quantify and map the dynamic properties of rhythmic oscillations. We also discuss how DBS alters the transient synchrony states of oscillatory networks in temporal and spatial domains during resting, task-based and motion conditions, and how this modulation of brain states ultimately shapes the functional response. Finally, we show how a successful decoding and management of electrophysiological proxies (beta bursts, phase-amplitude coupling) of aberrant brain circuits was translated into adaptive DBS stimulation paradigms for a targeted and state-dependent invasive electrical neuromodulation

Neurosurgery in Obsessive Compulsive Disorder:From targets to treatment to tracts and back again

People with obsessive compulsive disorder (OCD) suffer from obsessive thoughts and/or behavior, with a constant presence that can hardly be ignored. A range of interventions is effective in the management of OCD including behavioral therapy, cognitive therapy and cognitive behavioral therapy (CBT). In addition, a large body of evidence advocate on the use of selective serotonin reuptake inhibitors (SSRIs) and clomipramine, a tricyclic antidepressant, in the treatment of OCD, often used in combination with CBT. However, 40-60% of patients remain treatment-refractory, defined as a less than 25% reduction in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) score. This scale is used to determine the severity of the disorder. The resistance of such a big amount of patients to therapy may urge the need for alternative treatment strategies, such as deep brain stimulation (DBS) of subcortical structures or gamma knife ventral capsulotomy (GVC), a noninvasive procedure using gamma rays to destroy certain brain tissues. The first part of this thesis aimed at identifying fiber bundles associated with clinical response to DBS or GVC. OCD patients consistently underperform across multiple cognitive domains. The second part of this thesis was focused on the neuropsychological outcome of OCD DBS in order to identify a cognitive pattern associated with a good outcome or that would (in part) help explain the functional mechanism of OCD-DBS. The third part focused on several postoperative aspects of (OCD)-DBS patients including surgical and hardware related adverse events of DBS and reviewing the effectiveness, timing and procedural aspects of CBT after DBS with the aim to provide clinical recommendations

Clinical neuroscience and neurotechnology: An amazing symbiosis

In the last decades, clinical neuroscience found a novel ally in neurotechnologies, devices able to record and stimulate electrical activity in the nervous system. These technologies improved the ability to diagnose and treat neural disorders. Neurotechnologies are concurrently enabling a deeper understanding of healthy and pathological dynamics of the nervous system through stimulation and recordings during brain implants. On the other hand, clinical neurosciences are not only driving neuroengineering toward the most relevant clinical issues, but are also shaping the neurotechnologies thanks to clinical advancements. For instance, understanding the etiology of a disease informs the location of a therapeutic stimulation, but also the way stimulation patterns should be designed to be more effective/naturalistic. Here, we describe cases of fruitful integration such as Deep Brain Stimulation and cortical interfaces to highlight how this symbiosis between clinical neuroscience and neurotechnology is closer to a novel integrated framework than to a simple interdisciplinary interaction

Caracterización beta, gamma y de oscilaciones de alta frecuencia para localización de diana en procedimientos de Estimulación Cerebral Profunda

Deep Brain Stimulation (DBS) has been successfully used to treat patients with Parkinson’s Disease. DBS employs an electrode that regulates the oscillatory activity of the basal ganglia, such as the subthalamic nucleus (STN). A critical point during the surgical implantation of such electrode is the precise localization of the target. This is done using presurgical images, stereotactic frames, and microelectrode recordings (MER). The latter allows neurophysiologists to visualize the electrical activity of different structures along the surgical track, each of them with well-defined variations in the frequency pattern; however, this is far from an automatic or semi-automatic method to help these specialists make decisions concerning the surgical target. To pave the way to automation, we analyzed three frequency bands in MER signals acquired from 11 patients undergoing DBS: beta (13-40 Hz), gamma (40-200 Hz), and high-frequency oscillations (HFO – 201-400 Hz). In this study, we propose and assess five indexes in order to detect the STN: variations in autoregressive parameters and their derivative along the surgical track, the energy of each band calculated using the Yule-Walker power spectral density, the high-to-low (H/L) ratio, and its derivative. We found that the derivative of one parameter of the beta band and the H/L ratio of the HFO/gamma bands produced errors in STN targeting like those reported in the literature produced by image-based methods (<2 mm). Although the indexes introduced here are simple to compute and could be applied in real time, further studies must be conducted to be able to generalize their results.La estimulación cerebral profunda (DBS por sus siglas en inglés) ha sido usada exitosamente en el tratamiento de pacientes con enfermedad de Párkinson. La DBS tiene un electrodo que regula la actividad oscilatoria de los ganglios basales involucrados, como el núcleo subtalámico (STN). Un aspecto crítico en el implante de dicho electrodo es la localización precisa de la diana quirúrgica. Esta se realiza mediante imágenes pre-quirúrgicas, marcos estereotácticos y registros de micro-electrodos (MER). Este último permite visualizar la actividad eléctrica de diferentes estructuras a través del recorrido quirúrgico, cada una de ellas con un patrón de variaciones bien definidas en frecuencia; sin embargo, esto dista de ser un método automático o semi-automático que ayude al neurofisiólogo a tomar decisiones en cuanto a la diana quirúrgica. Con el ánimo de contribuir a la automatización, analizamos tres bandas de frecuencias de señales MER adquiridas en 11 pacientes sometidos a DBS: beta (13-40 Hz), gamma (40-200 Hz) y oscilaciones de alta frecuencia (HFO – 201-400 Hz). Se propusieron y evaluaron 5 índices para detectar el STN: variaciones de parámetros auto-regresivos y su derivada a lo largo del recorrido quirúrgico, la energía de cada banda a partir de la densidad espectral de potencia mediante el método de Yule-Walker, la relación de frecuencias altas a bajas y su derivada. Encontramos que la derivada de un parámetro de la banda beta y la relación alta-bajas de las bandas HFO/gamma alcanzaron errores en la localización del STN, similares a los reportados en la literatura (<2mm). Aunque los índices propuestos son sencillos de calcular y de fácil implementación en tiempo real, se deben seguir explorando para incrementar la capacidad de generalización de los resultados obtenidos

Optimization of the KNN Supervised Classification Algorithm as a Support Tool for the Implantation of Deep Brain Stimulators in Patients with Parkinson's Disease

Deep Brain Stimulation (DBS) of the Subthalamic Nuclei (STN) is the most used surgical treatment to improve motor skills in patients with Parkinson's Disease (PD) who do not adequately respond to pharmacological treatment, or have related side effects. During surgery for the implantation of a DBS system, signals are obtained through microelectrodes recordings (MER) at different depths of the brain. These signals are analyzed by neurophysiologists to detect the entry and exit of the STN region, as well as the optimal depth for electrode implantation. In the present work, a classification model is developed and supervised by the K-nearest neighbour algorithm (KNN), which is automatically trained from the 18 temporal features of MER registers of 14 patients with PD in order to provide a clinical support tool during DBS surgery. We investigate the effect of different standardizations of the generated database, the optimal definition of KNN configuration parameters, and the selection of features that maximize KNN performance. The results indicated that KNN trained with data that was standardized per cerebral hemisphere and per patient presented the best performance, achieving an accuracy of 94.35% (p < 0.001). By using feature selection algorithms, it was possible to achieve 93.5% in accuracy in selecting a subset of six features, improving computation time while processing in real time